Atrial fibrillation in heart failure: Prognostic significance and management

被引：30

作者：

Naccarelli, GV ^{[1
]}

Hynes, BJ

Wolbrette, DL

Bhatta, L

Khan, M

Samii, S

Luck, JC

机构：

[1] Penn State Univ, Coll Med, Div Cardiol, Hershey, PA 17033 USA

[2] Penn State Univ, Coll Med, Penn State Cardiovasc Ctr, Hershey, PA 17033 USA

来源：

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2003年 / 14卷 / 12期

关键词：

atrial fibrillation; heart failure;

D O I：

10.1046/j.1540-8167.2003.90404.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

引用

页码：S281 / S286

页数：6

共 76 条

[71] Dofetilide in patients with congestive heart failure and left ventricular dysfunction [J].

Torp-Pedersen, C ;

Moller, M ;

Bloch-Thomsen, PE ;

Kober, L ;

Sandoe, E ;

Egstrup, K ;

Agner, E ;

Carlsen, J ;

Videbæk, J ;

Marchant, B ;

Camm, AJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (12) :857-865

[72] Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery [J].

VanderLugt, JT ;

Mattioni, T ;

Denker, S ;

Torchiana, D ;

Ahern, T ;

Wakefield, LK ;

Perry, KT ;

Kowey, PR .

CIRCULATION, 1999, 100 (04) :369-375

[73] Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation [J].

Volgman, AS ;

Carberry, PA ;

Stambler, B ;

Lewis, WR ;

Dunn, GH ;

Perry, KT ;

Vanderlugt, JT ;

Kowey, PR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) :1414-1419

[74] Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation [J].

Vos, MA ;

Golitsyn, SR ;

Stangl, K ;

Ruda, MY ;

Van Wijk, L ;

Harry, JD ;

Perry, KT ;

Touboul, P ;

Steinbeck, G ;

Wellens, HJJ .

HEART, 1998, 79 (06) :568-575

[75] A comparison of rate control and rhythm control in patients with atrial fibrillation [J].

Wyse, DG ;

Waldo, AL ;

DiMarco, JP ;

Domanski, MJ ;

Rosenberg, Y ;

Schron, EB ;

Kellen, JC ;

Greene, HL ;

Mickel, MC ;

Dalquist, JE ;

Corley, SD .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23) :1825-1833

[76] New concepts in diastolic dysfunction and diastolic heart failure: Part I Diagnosis, prognosis, and measurements of diastolic function [J].

Zile, MR ;

Brutsaert, DL .

CIRCULATION, 2002, 105 (11) :1387-1393

← 1 2 3 4 5 6 7 8 →